CDC’s Investments to Combat Antibiotic Resistance Threats: Emergency Supplemental Funding Helps Stop the Spread of Emerging Infectious Disease Threats Fiscal Year 2023

Details

• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  Many of the nation’s efforts to respond to public health emergencies, such as preventing the spread of COVID-19, also help in the fight against antimicrobial resistance. This includes investments in IPC, training, surveillance, and public health personnel. The following represent many of those shared CDC public health activities funded by one-time emergency supplemental appropriations, such as the American Rescue Plan (ARP) Act or the Coronavirus Aid, Relief, and Economic Security (CARES) Act.
• Subjects:
  Antimicrobial Stewardship Carbapenem-Resistant Enterobacteriaceae Communicable Diseases, Emerging COVID-19/prevention & Control Cross Infection/prevention & Control Drug Resistance, Microbial Financing, Government Food Safety Global Health Local Government Pandemics Public Health State Government

  More +
• Series:
  Antibiotic Resistance (AR) Solutions in Action
• Document Type:
  Text
• Genre:
  Fact Sheet
• Pages in Document:
  3 numbered pages
• Federal Fiscal Year:
  2023
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:4ec960976940f0dbb6f43eea0a33044aa324768541dc8bc6e6f2b3d66fc0f6e7190d20eb002b69838ad95a1a50f71d61ced828959be2e6a20b91dfc0917d33bd
• Download URL:
  https://stacks.cdc.gov/view/cdc/150851/cdc_150851_DS1.pdf
• File Type:
  [PDF - 1.70 MB ]